Status:

COMPLETED

Study of Bimatoprost Gel on Eyelash Growth

Lead Sponsor:

Duke University

Conditions:

Madarosis

Hypotrichosis

Eligibility:

FEMALE

18-80 years

Phase:

PHASE3

Brief Summary

A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madaro...

Eligibility Criteria

Inclusion

  • 18-80 YO females
  • madarosis or hypotrichosis (loss of eyelashes) due to chemotherapy used to treat breast cancer
  • only breast cancer patients

Exclusion

  • inability to follow up, apply gel
  • active eye/eyelid infection or inflammatory process
  • cancer not related to breast cancer, healthy patients
  • males

Key Trial Info

Start Date :

February 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01200251

Start Date

February 1 2007

End Date

December 1 2008

Last Update

July 16 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke University Medical Center

Durham, North Carolina, United States, 27710